Literature DB >> 7773887

Controversy over use of pregnant mare's urine.

S A Clay.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7773887      PMCID： PMC1337964     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  19 in total

1.  Noncontraceptive hormone use and risk of breast cancer.

Authors:  C P Yang; J R Daling; P R Band; R P Gallagher; E White; N S Weiss
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

2.  Transdermal estradiol with oral progestin: biological and clinical effects in younger and older postmenopausal women.

Authors:  M F Bellantoni; S M Harman; V E Cullins; S M Engelhardt; M R Blackman
Journal:  J Gerontol       Date:  1991-11

3.  Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women.

Authors:  J C Stevenson; M P Cust; K F Gangar; T C Hillard; B Lees; M I Whitehead
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321

4.  A randomized comparison of nonoral estradiol delivery in postmenopausal women.

Authors:  F Z Stanczyk; D Shoupe; V Nunez; P Macias-Gonzales; M A Vijod; R A Lobo
Journal:  Am J Obstet Gynecol       Date:  1988-12       Impact factor: 8.661

5.  Relative risks and benefits of long-term estrogen replacement therapy: a decision analysis.

Authors:  R D Gorsky; J P Koplan; H B Peterson; S B Thacker
Journal:  Obstet Gynecol       Date:  1994-02       Impact factor: 7.661

6.  Direct modulation of osteoblastic activity with estrogen.

Authors:  R J Majeska; J T Ryaby; T A Einhorn
Journal:  J Bone Joint Surg Am       Date:  1994-05       Impact factor: 5.284

7.  Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study.

Authors:  G A Colditz; M J Stampfer; W C Willett; D J Hunter; J E Manson; C H Hennekens; B A Rosner; F E Speizer
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

8.  Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group.

Authors:  J D Woodruff; J H Pickar
Journal:  Am J Obstet Gynecol       Date:  1994-05       Impact factor: 8.661

Review 9.  Evaluating the benefits and risks of postmenopausal hormone therapy.

Authors:  S R Cummings
Journal:  Am J Med       Date:  1991-11-25       Impact factor: 4.965

10.  Effects of estropipate treatment on plasma lipids and lipoprotein lipid composition in postmenopausal women.

Authors:  J D Bagdade; P V Subbaiah
Journal:  J Clin Endocrinol Metab       Date:  1991-02       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.